Netherlands: argenx to acquire Forte Biosciences for US$2.2bn
Dutch/Belgian Euronext- and Nasdaq-listed argenx, a global immunology innovation company, is to acquire Nasdaq-listed Forte Biosciences, a clinical-stage…
#Netherlands #Nederland #NL #Europe #Europa #EU #argenx #Belgium #ForteBiosciences #Freshfields #GoldmanSachs #GuggenheimSecurities #KarenMassey #PaulWagner #WilsonSonsiniGoodrich&Rosati
https://www.europesays.com/netherlands/34246/